Display Settings:

Format

Send to:

Choose Destination
    Br J Cancer. 1998 Dec;78(12):1615-9.

    Smad4 (DPC4)--a potent tumour suppressor?

    Source

    Department of Pathology, The University of Edinburgh Medical School, UK.

    Abstract

    The recently described family of Smad molecules are essential mediators of transforming growth factor beta (TGF-beta) signalling. To date, seven members of this family have been identified, each of which plays a specific and separate role in mediating TGF-beta superfamily gene transcription. At least two different Smads, Smad2 and Smad4 (DPC4), have been implicated in human cancer and appear to have tumour-suppressor functions. Loss of function of Smad4 is most strongly associated with human pancreatic and colorectal malignancy. Furthermore, work from several different groups has suggested associations between Smad4 loss and malignancy in a number of other tissues. Here, we present a review of the current state of the literature implicating the central Smad mediator, Smad4, in the development of cancer.

    PMID:
    9862572
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2063251
    Free PMC Article

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk